Navigation Links
Attention New Jersey Physicians Still Needing to Meet Cultural Competency Requirement by June 30
Date:5/11/2009

BOSTON, May 11 /PRNewswire/ -- Manhattan Cross Cultural Group is now offering at a discounted price, the Quality Interactions(R) 6-hour CME cultural competency training course for physicians in New Jersey still needing to complete this requirement for licensure by June 30, 2009. New Jersey physicians can sign up for the training and receive a 25% discount by visiting: http://www.qualityinteractions.org/index.new.html and entering the following Promo Code at checkout: NJ_25.

Quality Interactions(R) highlights the key elements of the nationally recognized, cross-cultural curriculum published by Drs. Betancourt, Green and J. Emilio Carrillo in the Annals of Internal Medicine (Cross-Cultural Primary Care: A Patient-Based Approach. Ann Intern Med. 1999;130:829-834). The patient-based approach is centered on the idea that the patient themselves is your best source of information about their own cultural perspective versus learning a set of cultural traits and characteristics about a particular race or ethnicity that in turn, could lead to more stereotyping.

Quality Interactions(R) is built with e-learning technology, which is time-flexible and allows the physician to move at his/her own pace, at a time that is convenient for them. In addition, it provides personalized, real-time performance feedback, as well as a summary of key concepts at the conclusion of the program. The Quality Interactions(R) program has been utilized to train over 20,000 healthcare professionals around the country.

The program, which is specifically targeted to address the requirements of the NJ Senate Bill
'/>"/>

SOURCE Manhattan Cross Cultural Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. South Carolina Dermatologists Win Tennis Fans Attention With Free Skin Cancer Checks and Sun Safety Tips
2. Attention Runners: Run the 2009 Bank of America Chicago Marathon with Team Reeve
3. MedSolutions Joins Call for Increased Attention on Diagnostic Errors
4. GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder
5. Surgical Groups Form Operation Patient Access: Quality Surgical Care for All to Call Attention to Escalating Workforce Shortage
6. ADD-care -- A Natural, Homeopathic Alternative Reducing Symptoms Related to Attention Deficit Disorder
7. Brain abnormality found in boys with attention deficit hyperactivity disorder
8. Attention Snackers: Your Favorite Peanut Butter Bars Are Back!
9. Underlying sleep problem linked to attention-deficit/hyperactivity disorder in children
10. Absolutely PR's Maggie Holben Participates In CBSA BioBreakfast Expert Panel "How to Garner Media Attention & Effectively Use Public Relations Tactics"
11. Computer exercises improve memory and attention
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 2Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 3Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 4Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 5Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 6Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 7Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 8Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 9Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 2Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 3Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 4Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 5Remote Technologies Improve Patient Care, Viable Alternative to Intensivist Shortage 2Remote Technologies Improve Patient Care, Viable Alternative to Intensivist Shortage 3New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 1New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 2New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 3New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 4New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 5New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 6New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 7New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 8New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 9New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 10New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 11New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 12New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 13New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 14New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 15New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 16New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 17New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 18New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 19New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 20New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 21New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 22Hologic Expands Healthcare Investment in Asia 5563 1Hologic Expands Healthcare Investment in Asia 5563 2Hologic Expands Healthcare Investment in Asia 5563 3ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 1ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 2